Close
(0) items
You have no items in your shopping cart.
All Categories
    Filters
    Preferences
    Search

    Real-World Evidence in Drug Development and Evaluation

    €143.75
    This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE is the knowledge derived from aggregation and analysis of RWD.
    ISBN: 9780367026219
    AuthorYang, Harry
    SubAuthor1Yu, Binbing (MedImmune, LLC)
    Pub Date03/03/2021
    BindingHardback
    Pages178
    AvailabilityCurrently out of stock. If available, delivery is usually 5-10 working days.
    Availability: Out of Stock

    Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.

    Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.


    Features




    Provides the first book and a single source of information on RWE in drug development
    Covers a broad array of topics on outcomes- and value-based RWE assessments
    Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
    Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
    Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

    Write your own review
    • Only registered users can write reviews
    *
    *
    • Bad
    • Excellent
    *
    *
    *

    Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.

    Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.


    Features




    Provides the first book and a single source of information on RWE in drug development
    Covers a broad array of topics on outcomes- and value-based RWE assessments
    Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
    Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
    Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise